"With the outbreak of COVID-19, we want to ensure we are ready to care for the most critically ill patients while also meeting your needs. New or previously scheduled appointments may be changed to a video or phone visit so you can stay home and still receive quality care. Most prescriptions can be ordered via mail. Visit our website to schedule a virtual appointment, request mail order for your prescription or send an email to your doctor’s office. Our doctors are postponing elective or non-urgent surgeries and procedures."

During the past decade, Kaiser Permanente - Largo Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 20 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Largo Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Largo Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Largo Medical Center" are "Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Kaiser Permanente - Largo Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Largo Medical Center" are "Drug" (36 trials), "Other" (34 trials), "Biological" (18 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (10 trials), "Questionnaire Administration" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Largo Medical Center" are 31 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Largo Medical Center". undefined are not yet recruiting, 13 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Kaiser Permanente - Largo Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Largo Medical Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".